JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
Invesco China Technology ETF
CQQQ
$2.54B
| $2.46M | ﹤0.01% |
52,881
+6,454
| +14% | +$300K |
2020 Q3
10 quarters
|
|
3252
PUT
Waste Management
WM
$83.1B
| $2.46M | ﹤0.01% |
15,100
| – | – |
2022 Q3
2 quarters
|
|
3253
Adtran
ADTN
$621M
| $2.46M | ﹤0.01% |
154,850
-38,836
| -20% | -$674K |
2015 Q3
30 quarters
|
|
3254
International Seaways
INSW
$5.77B
| $2.45M | ﹤0.01% |
58,858
+4,886
| +9% | +$207K |
2016 Q4
25 quarters
|
|
3255
Dimensional International Small Cap Value ETF
DISV
$5.14B
| $2.45M | ﹤0.01% |
102,762
+15,802
| +18% | +$375K |
2022 Q4
1 quarter
|
|
3256
Invesco Leisure and Entertainment ETF
PEJ
$359M
| $2.44M | ﹤0.01% |
60,000
+59,967
| +181,718% | +$2.41M |
2022 Q4
1 quarter
|
|
3257
Protagonist Therapeutics
PTGX
$8.97B
| $2.44M | ﹤0.01% |
106,133
-197,029
| -65% | -$3.31M |
2017 Q4
21 quarters
|
|
|
NFBK
3258
DELISTED
Northfield Bancorp
NFBK
| $2.44M | ﹤0.01% |
206,834
-337,484
| -62% | -$4.83M |
2013 Q2
39 quarters
|
|
3259
iShares US Small Cap Equity Factor ETF
SMLF
$4.15B
| $2.43M | ﹤0.01% |
47,370
-37,840
| -44% | -$1.99M |
2022 Q4
1 quarter
|
|
|
PGTI
3260
DELISTED
PGT, Inc.
PGTI
| $2.43M | ﹤0.01% |
96,698
+35,632
| +58% | +$755K |
2016 Q1
28 quarters
|
|
3261
WisdomTree US High Dividend Fund
DHS
$1.56B
| $2.43M | ﹤0.01% |
29,501
+22,112
| +299% | +$1.89M |
2013 Q2
39 quarters
|
|
3262
Vanguard S&P Mid-Cap 400 ETF
IVOO
$3.77B
| $2.42M | ﹤0.01% |
28,635
+12,915
| +82% | +$1.11M |
2018 Q4
17 quarters
|
|
3263
Republic Bancorp
RBCAA
$1.83B
| $2.42M | ﹤0.01% |
56,974
-618
| -1% | -$26.7K |
2013 Q2
39 quarters
|
|
3264
Forrester Research
FORR
$214M
| $2.42M | ﹤0.01% |
74,711
+47,979
| +179% | +$1.66M |
2016 Q2
27 quarters
|
|
3265
St. Joe Company
JOE
$3.76B
| $2.41M | ﹤0.01% |
57,942
+10,726
| +23% | +$459K |
2013 Q2
39 quarters
|
|
3266
Sable Offshore Corp
SOC
$685M
| $2.41M | ﹤0.01% |
238,000
+88,000
| +59% | +$892K |
2021 Q2
7 quarters
|
|
3267
Avantis Emerging Markets Equity ETF
AVEM
$29B
| $2.41M | ﹤0.01% |
45,545
-1,114
| -2% | -$59.2K |
2022 Q4
1 quarter
|
|
|
ACH
3268
Accendra Health
ACH
$35.8M
| $2.4M | ﹤0.01% |
165,300
+18,273
| +12% | +$327K |
2013 Q2
39 quarters
|
|
3269
Revolve Group
RVLV
$1.51B
| $2.4M | ﹤0.01% |
91,455
+48,043
| +111% | +$1.24M |
2019 Q4
13 quarters
|
|
3270
Luxfer Holdings
LXFR
$465M
| $2.4M | ﹤0.01% |
142,236
-2,305
| -2% | -$37K |
2016 Q1
28 quarters
|
|
3271
Empire State Realty Trust
ESRT
$767M
| $2.4M | ﹤0.01% |
370,251
-33,278
| -8% | -$244K |
2014 Q4
33 quarters
|
|
3272
Koppers
KOP
$870M
| $2.4M | ﹤0.01% |
68,731
+39,471
| +135% | +$1.31M |
2015 Q3
30 quarters
|
|
3273
Eldorado Gold
EGO
$10.1B
| $2.39M | ﹤0.01% |
231,210
-66,411
| -22% | -$619K |
2013 Q2
39 quarters
|
|
3274
PUT
Bath & Body Works
BBWI
$3.62B
| $2.39M | ﹤0.01% |
65,300
+3,200
| +5% | +$134K |
2021 Q1
8 quarters
|
|
3275
Zillow
ZG
$6.38B
| $2.38M | ﹤0.01% |
54,460
+44,183
| +430% | +$1.84M |
2020 Q1
12 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.